Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 210
Phase 34

Trial Status

Recruiting1
Terminated1
Other10

Role Distribution

Principal Investigator12
PI Rate100%

Activity Timeline

Clinical Trials (12)

NCT05077072Phase 2Active Not Recruiting
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
Head and Neck Carcinoma
PrincipalinvestigatorStart date: 2021-10-08
NCT03927885Phase 2/3Active Not Recruiting
Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2019-03-30
NCT03747757Phase 2Active Not Recruiting
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeCancer Fatigue+2 more
PrincipalinvestigatorStart date: 2018-11-29
NCT03637816Phase 2/3Active Not Recruiting
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer
AnorexiaLung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
PrincipalinvestigatorStart date: 2018-11-27
NCT03525873Phase 3Active Not Recruiting
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm
PrincipalinvestigatorStart date: 2018-08-02
NCT03583255Phase 2Active Not Recruiting
Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer
Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid System NeoplasmLocally Advanced Malignant Solid Neoplasm+2 more
PrincipalinvestigatorStart date: 2018-06-29
NCT02940223Phase 2Terminated
Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer
Advanced Malignant NeoplasmFatigue
PrincipalinvestigatorStart date: 2017-03-16
NCT03035409Phase 2Active Not Recruiting
Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
Advanced Malignant Solid NeoplasmC-Reactive Protein MeasurementCancer Fatigue+3 more
PrincipalinvestigatorStart date: 2017-02-08
NCT02491632Phase 2/3Active Not Recruiting
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
Advanced Malignant NeoplasmFatigueMetastatic Malignant Neoplasm+2 more
PrincipalinvestigatorStart date: 2015-08-13

Showing 10 of 12 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmLocally Advanced Malignant Solid NeoplasmStage III Lung Cancer AJCC v8+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

AnorexiaAdvanced Malignant Solid NeoplasmFatigue+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LymphomaLeukemia, Myeloid, Acute

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

FatigueWeight Loss
Similarity Score2%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

LymphomaWeight Loss
Similarity Score2%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

FatigueSleep Disorders

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (12)

Showing 12 of 12 trials

NCT05077072Phase 2PrincipalInvestigator

Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients

Head and Neck Carcinoma
Active Not Recruiting
NCT04984551Phase 2PrincipalInvestigator

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Recruiting
NCT03927885Phase 2/3PrincipalInvestigator

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
Active Not Recruiting
NCT03747757Phase 2PrincipalInvestigator

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeCancer Fatigue+2 more
Active Not Recruiting
NCT03637816Phase 2/3PrincipalInvestigator

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

AnorexiaLung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
Active Not Recruiting
NCT03525873Phase 3PrincipalInvestigator

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm
Active Not Recruiting
NCT03583255Phase 2PrincipalInvestigator

Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer

Advanced Malignant Solid NeoplasmHematopoietic and Lymphoid System NeoplasmLocally Advanced Malignant Solid Neoplasm+2 more
Active Not Recruiting
NCT02940223Phase 2PrincipalInvestigator

Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

Advanced Malignant NeoplasmFatigue
Terminated
NCT03035409Phase 2PrincipalInvestigator

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

Advanced Malignant Solid NeoplasmC-Reactive Protein MeasurementCancer Fatigue+3 more
Active Not Recruiting
NCT02491632Phase 2/3PrincipalInvestigator

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Advanced Malignant NeoplasmFatigueMetastatic Malignant Neoplasm+2 more
Active Not Recruiting
NCT01628029Phase 2PrincipalInvestigator

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSleep Disorder
Active Not Recruiting
NCT05044312Not ApplicablePrincipalInvestigator

Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis

Gastrointestinal CancerGI Cancers
Withdrawn

All 12 trials loaded